In a remarkable event, Kevin Piette, a paraplegic, carried the Olympic torch in Paris using an exoskeleton from Wandercraft SAS. This event marked a significant milestone for both Piette and Wandercraft, highlighting advancements in exoskeleton technology aimed at aiding individuals with mobility impairments. The choice of Piette, who has been paraplegic since a motorcycle accident 11 years ago, underscored the potential of assistive technology to transform lives.
Exoskeleton Innovations in Olympic Relay
Wandercraft announced that Piette, a trained test pilot for the company, was the first to use a self-balancing exoskeleton in the Olympic torch relay. The Paris-based company specializes in developing robotic exoskeletons designed to help people with disabilities walk. Currently, Wandercraft offers the FDA-cleared Atalante X exoskeleton, which assists individuals with spinal cord injuries to regain mobility.
The exoskeleton used by Piette is a prototype in the final stages of research and development. Wandercraft plans to conduct usability and clinical trials soon. A company spokesperson said,
“We are thrilled to see our technology showcased in such a significant event, demonstrating its real-world applications and potential to change lives.”
Company’s Milestones and Financial Support
This year, Wandercraft secured over €25 million ($27 million) in financing from the European Investment Bank to further develop its exoskeleton technology and expand patient access. CEO Matthieu Masselin stated,
“At Wandercraft, our focus is on improving patient outcomes and creating a world where everyone can stand up and walk.”
The company intends to leverage this funding to accelerate the availability of their devices, including the Atalante X and the Personal Exoskeleton.
Earlier accounts of Wandercraft’s exoskeletons showcased the Atalante X model already being used in rehabilitation centers. The FDA approval of Atalante X for specific spinal injury levels has been a significant milestone. Unlike previous updates that focused solely on medical facilities, the recent development of the Personal Exoskeleton indicates a shift towards personal use, broadening the scope of the technology’s application.
Recent reports also highlighted the financial boost from the EIB, emphasizing Wandercraft’s commitment to innovation in mobility solutions. This financial support is expected to expedite research and development, leading to quicker market readiness for their exoskeletons.
Wandercraft’s advancements in exoskeleton technology have shown significant promise in helping individuals with mobility impairments regain independence. The company’s focus on clinical trials and obtaining regulatory approvals indicates their commitment to ensuring safety and efficacy before commercial release. As the exoskeleton technology progresses, more individuals may benefit from these devices, enhancing their quality of life and mobility.
- Paraplegic carried the Olympic torch using Wandercraft’s exoskeleton.
- Wandercraft develops robotic exoskeletons to aid mobility-impaired individuals.
- Company plans usability and clinical trials for its new exoskeleton.
